Should Urine-LAM Tests Be Used in TB Symptomatic HIV-Positive Patients When No CD4 Count Is Available? A Prospective Observational Cohort Study From Malawi

Current eligibility criteria for urine lateral-flow lipoarabinomannan assay (LF-LAM) in ambulatory, HIV-positive patients rely on the CD4 count. We investigated the diagnostic yield of LF-LAM and the 6-month mortality in ambulatory, TB symptomatic, HIV-positive patients regardless of their CD4 count...

Descripción completa

Detalles Bibliográficos
Autores principales: Huerga, Helena, Rucker, Sekai Chenai Mathabire, Bastard, Mathieu, Dimba, Andrew, Kamba, Cosmas, Amoros, Isabel, Szumilin, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2020
Materias:
Implementation Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903332/
https://www.ncbi.nlm.nih.gov/pubmed/31633613
http://dx.doi.org/10.1097/QAI.0000000000002206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903332/
https://www.ncbi.nlm.nih.gov/pubmed/31633613
http://dx.doi.org/10.1097/QAI.0000000000002206

Ejemplares similares